To celebrate, we asked the brilliant women in our sector their one main positive to come from the pandemic.
Paul Major, fund manager, BB Healthcare Trust shares his thoughts on the … Continue reading “Vaccines’ Progress: Paul Major Interview”
Optimum supports Anglonordic, the only life science conference in the UK that is exclusively for European investors and R&D companies from the Nordics and the UK to connect with each other.
European innovators helped pave the way for the world’s first COVID-19 vaccines. What’s coming next from Europe’s academic and biotech leaders?
To be credible and investible, ESG is becoming critical to the fund manager’s perspective, as investors shift further to sustainable investment.
February is Heart Awareness Month. In this Insight, Karin Kleinhans of LSP discusses how heart failure, one of the leading causes of death worldwide, is a global problem that demands urgent attention.
Francesco de Rubertis, a co-founder of Medicixi Ventures, has unveiled the next … Continue reading “BioWorld Article by Mike Ward on Medicxi’s launch of Centessa Pharmaceuticals”
CEO Neil Clark and CSO Dr Bill Love from Europe’s leading anti-infectives biotech company Destiny Pharma, on how the makers and influencers of health policy could fuel a renaissance in drug development…
Novo Seeds had a very successful year with five investments. Also, substantial progress has been made across the 25 biotech companies in the portfolio, with 12 drug candidates now in the clinic.
2021: Priorities for European Pharma & What does the investment landscape look like post Covid-19?
From surviving to thriving as 2021 takes the reins from 2020. In a year turned on its head by the pandemic, witnessing this month the unprecedented roll out of a novel coronavirus vaccine, with several more vaccines on the horizon, December has become a time of hope…
Whilst the news is, finally, full of promising updates on vaccines, the world will need a wide range of prophylactic and therapeutic approaches to defeat the coronavirus.
Jonathan Tobin, Managing Director of Arix, talks to Vox Markets
Start planning early for the Virtual J.P. Morgan Healthcare Conference (“JPM”)
Against the backdrop of the pandemic and Brexit, Biocomposites’ lead product STIMULAN became the first calcium matrix to receive European approval as an antibiotic carrier for use in bone and soft-tissue.
Fireside Chat: ‘Communicating to investors through a crisis’ Chaired by Mary Clark, with Kevin Mannix, Head of IR at Teva, and Oliver Maier, Head of IR at Bayer
Fireside Chat with Dan Mahony, Co-head of Healthcare, Polar Capital & Kieran Murphy, President & CEO, GE Healthcare
Tuning in to the field of targeted cancer medicine through molecular radiotherapy or targeted radionuclides.
Congratulations to Kiadis Pharma on recently announcing that it is being acquired by Sanofi in a … Continue reading “Sanofi offers to acquire Kiadis for €308 million”
For more information about Optimum Strategic Communications, please get in touch
We'd love to hear from you...GET IN TOUCH